境外上市
Search documents
政策宽松环境下,零碳环保预计较快完成纳斯达克IPO
Sou Hu Wang· 2025-06-14 06:40
Group 1 - The core viewpoint of the article highlights the favorable conditions for Carbon Zero Technologies International Inc. (CZTI) to complete its IPO on NASDAQ, supported by macroeconomic factors, policy backing, and the company's competitive strength [1] - CZTI has received a new stock issuance registration letter (Form 8-A12B) from the SEC, indicating progress in its overseas listing process [1] - The company reported a significant revenue growth of 4.5 billion in 2024, showcasing its strategic development and market scale effects [1] Group 2 - The main underwriter for the IPO is Ninth Eternity Securities LLC, with legal representation from Crone Law Group P.C. in the U.S. and Zhong Lun Law Firm in China, along with auditing by Marcum Asia CPAs LLP [2]
酷特智能:拟境外发行股份并在香港联交所上市
news flash· 2025-06-10 12:38
Core Viewpoint - The company plans to initiate the process for issuing H-shares and listing on the Hong Kong Stock Exchange to enhance its global strategy and capital strength [1] Group 1 - The fourth board meeting of the company is scheduled for June 10, 2025, to review the proposal for H-share issuance [1] - The company aims to strengthen its international capital operation platform and overall competitiveness through this H-share listing [1] - The board intends to authorize the management to start preliminary preparations for the H-share listing [1] Group 2 - The company will discuss specific steps for the H-share listing with relevant intermediaries [1] - Details regarding the H-share listing are yet to be determined [1]
潮宏基拟发行H股 去年净利降4成今年一季度现金流为负
Zhong Guo Jing Ji Wang· 2025-06-10 03:24
Core Viewpoint - Chao Hong Ji (潮宏基) plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy, brand image, and competitiveness [1][2] Financial Performance - In 2024, the company achieved a revenue of 6.52 billion yuan, a year-on-year increase of 10.48%, while net profit attributable to shareholders decreased by 41.91% to 194 million yuan [2][3] - The net profit excluding non-recurring gains and losses was 187 million yuan, down 38.72% compared to the previous year [2][3] - The net cash flow from operating activities was 435 million yuan, a decline of 29.22% year-on-year [2][3] Recent Quarterly Results - For Q1 2025, the company reported a revenue of 2.25 billion yuan, reflecting a year-on-year growth of 25.36% [4] - The net profit attributable to shareholders for Q1 2025 was 189 million yuan, up 44.38% year-on-year [4] - The net profit excluding non-recurring gains and losses for Q1 2025 was 188 million yuan, an increase of 46.17% compared to the same period last year [4] Shareholding Structure - As of the end of Q1 2025, the controlling shareholder, Shantou Chao Hong Ji Investment Co., held 28.55% of the shares, with 31% of these shares pledged [4][5] - The chairman and general manager, Liao Chuangbin, holds 3.04% of the shares, with 48% of his holdings also pledged [4][5]
香港证监会出手遏制违法金融网红活动;佰泽医疗通过港交所聆讯丨港交所早参
Mei Ri Jing Ji Xin Wen· 2025-06-08 23:57
Group 1 - The Hong Kong Securities and Futures Commission (SFC) issued a restriction notice to Huanlian International Asset Management due to concerns about its reliability, integrity, and ability to conduct regulated activities properly [1] - The SFC's action reflects high standards required from market participants to ensure market fairness and transparency [1] Group 2 - The SFC is collaborating with global regulatory bodies to curb illegal activities by financial influencers who promote financial products on social media, potentially putting millions of users at risk [2] - The effectiveness of the SFC's efforts will be enhanced through cooperation with other regulators, emphasizing the need for investors to verify the regulatory status and credibility of financial influencers before making investment decisions [2] Group 3 - Baize Medical Group passed the Hong Kong Stock Exchange (HKEX) listing hearing and is expected to list soon, focusing on oncology medical services through ownership and management of multiple hospitals [3] - The projected revenues for Baize Medical from 2022 to 2024 are 803 million, 1.072 billion, and 1.189 billion respectively, indicating growth potential in the healthcare sector [3] Group 4 - Stone Technology, a manufacturer of smart cleaning robots, announced plans to issue shares and list on the HKEX to enhance its global brand recognition and competitiveness [4] - This move aims to optimize capital structure, diversify financing channels, and strengthen corporate governance, positioning the company to capitalize on the growing demand for smart cleaning robots [4] Group 5 - The latest performance of the Hong Kong stock market shows the Hang Seng Index at 23,792.54, down 0.48%, the Hang Seng Tech Index at 5,286.52, down 0.63%, and the National Enterprises Index at 8,629.75, also down 0.63% [5]
奥杰股份(AOJE.US)拟美股上市 中国证监会要求补充说明股权架构合规性等事项
智通财经网· 2025-06-06 11:52
三、请说明:你公司是否属于"高耗能"、"高排放"行业,请核查已建、在建及拟建项目是否属于"高耗 能"、"高排放"项目。 一、请说明:你公司股权控制架构设立的合规性,包括但不限于搭建和返程投资涉及的各主体履行外汇 管理、境外投资、外商投资、税务等监管程序的具体情况,是否依法合规;发行人取得境内实体鹰潭拓 新机电有限公司的支付手段及其合规性,股权转让环节相关转让方纳税申报缴纳情况,是否符合《关于 外国投资者并购境内企业的规定》;请列表说明奥杰英科(苏州)新材有限公司股东和发行人层面股东持股 比例对应情况。 二、请说明:你公司12个月内新增股东入股价格的定价依据及合理性。 智通财经APP获悉,6月6日,中国证监会公布境外发行上市备案补充材料要求公示(2025年5月30日— 2025年6月5日)。证监会要求奥杰股份(AOJE.US)补充说明公司股权控制架构设立的合规性,12个月内新 增股东入股价格的定价依据及合理性等事项。据悉,奥杰股份正稳步推进在美上市进程,拟在纳斯达克 上市。 证监会请奥杰股份补充说明以下事项,请律师进行核查并出具明确的法律意见: 资料显示,奥杰股份主营抗菌环保新材料的研发、生产与销售。总部位于汾 ...
石 头 科 技: 北京石头世纪科技股份有限公司关于制定公司于H股发行上市后适用的《公司章程(草案)》及相关内部治理制度的公告
Zheng Quan Zhi Xing· 2025-06-06 10:37
证券代码:688169 证券简称:石 头 科 技 公告编号:2025-048 北京石头世纪科技股份有限公司 关于制定公司于 H 股发行上市后适用的《公司章程(草案)》 及相关内部治理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 北京石头世纪科技股份有限公司(以下简称"公司")于 2025 年 6 月 6 日 召开第三届董事会第七次会议,审议通过了《关于修订公司于 H 股发行上市后 适用的 <公司章程 草案="草案"> 及相关议事规则(草案)的议案》《关于修订公司 于 H 股发行上市后适用的内部治理制度的议案》等相关议案。现将具体情况公 告如下: 一、制定《公司章程(草案)》情况 基于公司拟于境外发行股份(H 股)并在香港联合交易所有限公司(以下简 称"香港联交所")主板上市(以下简称"本次发行 H 股并上市")的需要, 根据《中华人民共和国公司法》《境内企业境外发行证券和上市管理试行办法》 等境内法律、法规、规范性文件及《香港联交所上市规则》 ...
海南华铁:筹划境外发行股份并在新加坡交易所上市
news flash· 2025-06-04 10:01
Core Viewpoint - Hainan Huatie (603300) is planning to issue shares overseas and list on the Singapore Exchange as part of its internationalization strategy [1] Group 1 - The company is currently in discussions with relevant intermediaries regarding the specific progress of the S-share listing [1] - The S-share listing will not result in changes to the company's controlling shareholder or actual controller [1] - The specific plan for the S-share listing will need to be submitted for approval by the company's board of directors and shareholders' meeting, and will also require filing with the China Securities Regulatory Commission and approval from regulatory bodies in Singapore [1]
国民技术: 第六届监事会第五次会议决议公告
Zheng Quan Zhi Xing· 2025-05-30 12:14
Core Viewpoint - The company, Guomin Technology Co., Ltd., plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international presence and competitiveness [1][2]. Group 1: Meeting Details - The sixth session of the company's supervisory board was held on May 29, 2025, with all three supervisors present [1]. - The meeting was convened in accordance with the Company Law of the People's Republic of China and the company's articles of association, ensuring the legality and validity of the resolutions [1]. Group 2: H-Share Issuance Proposal - The supervisory board approved the proposal for issuing H-shares and applying for listing on the Hong Kong Stock Exchange to accelerate the company's overseas strategic layout [1][2]. - The proposal received unanimous support with 3 votes in favor, 0 against, and 0 abstentions [2]. Group 3: Issuance Details - The H-shares will have a nominal value of RMB 1.00 and will be issued in foreign currency [2]. - The company plans to issue no more than 20% of its total share capital in H-shares post-listing, subject to shareholder approval [4]. Group 4: Fund Utilization Plan - The funds raised from the H-share issuance will be used for R&D, repaying bank loans, and supplementing working capital [8][9]. - If the raised funds are insufficient for project needs, the company will seek alternative funding solutions [8]. Group 5: Regulatory Compliance - The issuance will comply with relevant laws and regulations, including the Listing Rules of the Hong Kong Stock Exchange [2][3]. - The company will determine the specific issuance timing based on market conditions and regulatory approvals [3]. Group 6: Insurance and Audit - The company plans to purchase liability insurance for directors and senior management, subject to shareholder approval [10]. - Deloitte will be appointed as the auditing firm for the H-share issuance [11].
国恩股份: 第五届监事会第十一次会议决议公告
Zheng Quan Zhi Xing· 2025-05-26 13:18
股票代码:002768 股票简称:国恩股份 公告编号:2025-024 青岛国恩科技股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 青岛国恩科技股份有限公司(以下简称"公司"或"国恩股份")第五届监 事会第十一次会议于 2025 年 5 月 26 日 15:30 在青岛市城阳区棘洪滩街道青大工 业园 2 号路公司四楼会议室召开。本次会议由监事会主席王龙先生提议召开并主 持,会议通知于 2025 年 5 月 23 日以专人送达、电子邮件、电话等形式发出。本 次会议应到监事 3 名,实到监事 3 名。本次会议的召集、召开和表决程序符合 《中华人民共和国公司法》(以下简称"《公司法》")等法律法规和《青岛国 恩科技股份有限公司章程》(以下简称"《公司章程》")的有关规定,合法有 效。 二、监事会会议审议情况 议案》 公司发行境外上市外资股(H 股)股票并申请于香港联合交易所有限公司 (以下简称"香港联交所")主板挂牌上市(以下简称"本次发行"、"本次发 行上市"或"本次发行并上市")有利于深入推进公司全球化战略布局,打造国 际化 ...
韦尔股份: 第六届监事会第三十五次会议决议公告
Zheng Quan Zhi Xing· 2025-05-23 10:10
证券代码:603501 证券简称:韦尔股份 公告编号:2025-052 转债代码:113616 转债简称:韦尔转债 上海韦尔半导体股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 上海韦尔半导体股份有限公司(以下简称"公司")第六届监事会第三十 五次会议于2025年5月23日以现场结合通讯方式召开,会议通知已于2025年5月 应到监事3人,实到监事3人。本次会议的召集和召开符合《公司法》等有关法 律、行政法规、部门规章、规范性文件和《公司章程》的有关规定,会议形成 的决议合法、有效。 二、监事会会议审议情况 (一)审议通过《关于公司发行 H 股股票并在香港联合交易所有限公司主 板上市的议案》 为加快公司的国际化战略及海外业务发展,增强公司的境外融资能力,进 一步提高公司的综合竞争力,根据公司总体发展战略及运营需要,公司拟发行 境外上市股份(H 股)并在香港联合交易所有限公司(以下简称"香港联交 所")主板上市(以下简称"本次发行 H 股并上市"或"本次发行")。 根据《中华人民共和国公司法》 ...